According to Anavex Life Sciences 's latest financial reports the company's total assets are โน10.62 Billion. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2024-09-30 | โน11.34 B | -11.62% |
2023-09-30 | โน12.84 B | 3.21% |
2022-09-30 | โน12.44 B | 3.59% |
2021-09-30 | โน12.01 B | 370.9% |
2020-09-30 | โน2.55 B | 42.85% |
2019-09-30 | โน1.78 B | -6.03% |
2018-09-30 | โน1.90 B | 4.52% |
2017-09-30 | โน1.81 B | 186.47% |
2016-09-30 | โน0.63 B | -37.76% |
2015-09-30 | โน1.01 B | 125.3% |
2014-09-30 | โน0.45 B | 1728.67% |
2013-09-30 | โน24.75 M | 3460.32% |
2012-09-30 | โน0.69 M | -92.99% |
2011-09-30 | โน9.92 M | -32.7% |
2010-09-30 | โน14.74 M | -24.55% |
2009-09-30 | โน19.53 M | 5707.52% |
2008-09-30 | โน0.33 M | 33822.82% |
2007-09-30 | โน0 M | -99.83% |
2006-09-30 | โน0.57 M | 1233.06% |
2005-09-30 | โน0.04 M | -96.67% |
2004-09-30 | โน1.28 M |